{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T05:23:09Z","timestamp":1776576189967,"version":"3.51.2"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T00:00:00Z","timestamp":1775347200000},"content-version":"am","delay-in-days":308,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["1R16GM145586"],"award-info":[{"award-number":["1R16GM145586"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bbadis.2025.167822","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T02:11:23Z","timestamp":1743559883000},"page":"167822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Improving the safety of N,N-dimethylacetamide (DMA) as a potential treatment for preterm birth in a pregnant mouse model using a vaginal nanoformulation"],"prefix":"10.1016","volume":"1871","author":[{"given":"Asad","family":"Mir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teeshavi","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Concheiro-Guisan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Yellon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ketan","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra E.","family":"Reznik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.bbadis.2025.167822_bb0005","first-page":"1444","article-title":"FDA revokes approval for preterm birth drug Makena","volume":"329","author":"Harris","year":"2023","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.bbadis.2025.167822_bb0010","article-title":"Preterm birth: an overview","volume":"14","author":"Khandre","year":"2022","journal-title":"Cureus"},{"issue":"8","key":"10.1016\/j.bbadis.2025.167822_bb0015","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1053\/j.semperi.2017.08.010","article-title":"Racial and ethnic differences in preterm birth: a complex, multifactorial problem","volume":"41","author":"Manuck","year":"2017","journal-title":"Semin. Perinatol."},{"issue":"2","key":"10.1016\/j.bbadis.2025.167822_bb0020","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0039-3400227","article-title":"17-OHPC to prevent recurrent preterm birth in singleton gestations (PROLONG study): a multicenter, international, randomized double-blind trial","volume":"37","author":"Blackwell","year":"2020","journal-title":"Am. J. Perinatol."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167822_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajog.2023.08.031","article-title":"The end is where we start from: withdrawal of 17-alpha hydroxyprogesterone caproate to prevent recurrent preterm birth","volume":"230","author":"Nelson","year":"2024","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"1","key":"10.1016\/j.bbadis.2025.167822_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2004.01.025","article-title":"Why consider vaginal drug administration?","volume":"82","author":"Alexander","year":"2004","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167822_bb0035","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1067\/mob.2003.341","article-title":"Placement of the vaginal 17beta-estradiol tablets in the inner or outer one third of the vagina affects the preferential delivery of 17beta-estradiol toward the uterus or periurethral areas, thereby modifying efficacy and endometrial safety","volume":"189","author":"Cicinelli","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.bbadis.2025.167822_bb0040","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.addr.2021.04.021","article-title":"Next generation strategies for preventing preterm birth","volume":"174","author":"Zierden","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.bbadis.2025.167822_bb0045","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.3390\/pharmaceutics14102019","article-title":"Vaginal Nanoformulations for the Management of Preterm Birth","volume":"14","author":"Mir","year":"2022","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.bbadis.2025.167822_bb0050","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/humrep\/12.5.1073","article-title":"Targeted drug delivery in gynaecology: the first uterine pass effect","volume":"12","author":"Bulletti","year":"1997","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/j.bbadis.2025.167822_bb0055","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jconrel.2004.11.034","article-title":"The vagina as a route for systemic drug delivery","volume":"103","author":"Hussain","year":"2005","journal-title":"J. Control. Release"},{"issue":"138","key":"10.1016\/j.bbadis.2025.167822_bb0060","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003453","article-title":"Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus","volume":"4","author":"Ensign","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.bbadis.2025.167822_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266296","article-title":"Development of mucus-penetrating iodine loaded self-emulsifying system for local vaginal delivery","volume":"17","author":"Fida","year":"2022","journal-title":"PloS One"},{"issue":"10","key":"10.1016\/j.bbadis.2025.167822_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110918","article-title":"Formulation of the microbicide INP0341 for in vivo protection against a vaginal challenge by Chlamydia trachomatis","volume":"9","author":"Pedersen","year":"2014","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.bbadis.2025.167822_bb0075","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3390\/pharmaceutics11070335","article-title":"17-\u03b1 hydroxyprogesterone nanoemulsifying preconcentrate-loaded vaginal tablet: a novel non-invasive approach for the prevention of preterm birth","volume":"11","author":"Patki","year":"2019","journal-title":"Pharmaceutics"},{"issue":"21","key":"10.1016\/j.bbadis.2025.167822_bb0080","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.2217\/nnm-2019-0243","article-title":"A vaginal nanoformulation of a SphK inhibitor attenuates lipopolysaccharide-induced preterm birth in mice","volume":"14","author":"Giusto","year":"2019","journal-title":"Nanomedicine (Lond.)"},{"issue":"21","key":"10.1016\/j.bbadis.2025.167822_bb0085","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.3390\/ijms21218266","article-title":"The cervicovaginal mucus barrier","volume":"21","author":"Lacroix","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.167822_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1015625","article-title":"Cervicovaginal mucus barrier properties during pregnancy are impacted by the vaginal microbiome","volume":"13","author":"Zierden","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"4","key":"10.1016\/j.bbadis.2025.167822_bb0095","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00192-012-2009-3","article-title":"The vagina as a route for drug delivery: a review","volume":"24","author":"Srikrishna","year":"2013","journal-title":"Int. Urogynecol. J."},{"issue":"8","key":"10.1016\/j.bbadis.2025.167822_bb0100","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/17425247.2019.1645117","article-title":"Recent advances in the mucus-interacting approach for vaginal drug delivery: from mucoadhesive to mucus-penetrating nanoparticles","volume":"16","author":"Silvia Rossi","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"issue":"4","key":"10.1016\/j.bbadis.2025.167822_bb0105","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1021\/acsmacrolett.2c00639","article-title":"PH-responsive mucus-penetrating nanoparticles for enhanced cellular internalization by local administration in vaginal tissue","volume":"12","author":"Zhang","year":"2023","journal-title":"ACS Macro Lett."},{"issue":"7","key":"10.1016\/j.bbadis.2025.167822_bb0110","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1039\/D2NA00834C","article-title":"Nanomedicine strategies to improve therapeutic agents for the prevention and treatment of preterm birth and future directions","volume":"5","author":"Taylor","year":"2023","journal-title":"Nanoscale Advances"},{"issue":"12","key":"10.1016\/j.bbadis.2025.167822_bb0115","doi-asserted-by":"crossref","first-page":"6455","DOI":"10.3390\/ijms22126455","article-title":"Emulsion-based multicompartment vaginal drug carriers: from nanoemulsions to nanoemulgels","volume":"22","author":"Smole\u0144ski","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.167822_bb0120","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2147\/IJN.S184723","article-title":"A review of small molecules and drug delivery applications using gold and iron nanoparticles","volume":"14","author":"Jahangirian","year":"2019","journal-title":"Int. J. Nanomedicine"},{"issue":"3","key":"10.1016\/j.bbadis.2025.167822_bb0125","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3390\/pharmaceutics15030774","article-title":"Approved nanomedicine against diseases","volume":"15","author":"Jia","year":"2023","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.bbadis.2025.167822_bb0130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/2231-4040.82950","article-title":"Nanosuspension: an approach to enhance solubility of drugs","volume":"2","author":"Patel","year":"2011","journal-title":"J. Adv. Pharm. Technol. Res."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167822_bb0135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/biolre\/ioac182","article-title":"Is human labor at term an inflammatory condition?","volume":"108","author":"Kyathanahalli","year":"2023","journal-title":"Biol. Reprod."},{"issue":"Suppl. 1","key":"10.1016\/j.bbadis.2025.167822_bb0140","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/1471-2393-7-S1-S7","article-title":"Inflammatory pathways in the mechanism of parturition","volume":"7","author":"Norman","year":"2007","journal-title":"BMC Pregnancy Childbirth"},{"issue":"2","key":"10.1016\/j.bbadis.2025.167822_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.105953","article-title":"Dynamic states of cervical epithelia during pregnancy and epithelial barrier disruption","volume":"26","author":"Cooley","year":"2023","journal-title":"iScience"},{"issue":"3","key":"10.1016\/j.bbadis.2025.167822_bb0150","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/biolre\/iox146","article-title":"Progesterone, the maternal immune system and the onset of parturition in the mouse\u2020","volume":"98","author":"Edey","year":"2017","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.bbadis.2025.167822_bb0155","first-page":"747","article-title":"N,N-dimethylacetamide significantly attenuates LPS- and TNF\u03b1-induced proinflammatory responses via inhibition of the nuclear factor kappa B pathway","volume":"22","author":"Pekson","year":"2016","journal-title":"Molecular Medicine (Cambridge, Mass.)"},{"issue":"2","key":"10.1016\/j.bbadis.2025.167822_bb0160","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ajpath.2013.05.006","article-title":"N,N-dimethylacetamide regulates the proinflammatory response associated with endotoxin and prevents preterm birth","volume":"183","author":"Sundaram","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2025.167822_bb0165","series-title":"The Guide to Investigation of Mouse Pregnancy","first-page":"539","article-title":"Protocols for placental histology","author":"Bolon","year":"2014"},{"issue":"4","key":"10.1016\/j.bbadis.2025.167822_bb0170","first-page":"3482","article-title":"Abnormal angiogenesis of placenta in progranulin-deficient mice","volume":"22","author":"Xu","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbadis.2025.167822_bb0175","first-page":"2763","article-title":"DNA extraction from paraffin embedded material for genetic and epigenetic analyses","volume":"49","author":"Pikor","year":"2011","journal-title":"J. Vis. Exp."},{"issue":"4","key":"10.1016\/j.bbadis.2025.167822_bb0180","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1258\/la.2010.010011","article-title":"Sublingual and submandibular blood collection in mice: a comparison of effects on body weight, food consumption and tissue damage","volume":"44","author":"Heimann","year":"2010","journal-title":"Lab. Anim"},{"issue":"10","key":"10.1016\/j.bbadis.2025.167822_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/jssc.202201003","article-title":"Validation of a liquid chromatography-tandem mass spectrometry method for simultaneous quantification of N,N-dimethylacetamide and N-monomethylacetamide in pediatric plasma","volume":"46","author":"Rosser","year":"2023","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.bbadis.2025.167822_bb0190","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fcell.2018.00080","article-title":"Mouse yolk sac hematopoiesis","volume":"6","author":"Yamane","year":"2018","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"2\u20133","key":"10.1016\/j.bbadis.2025.167822_bb0195","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1387\/ijdb.082768dh","article-title":"Development and function of trophoblast giant cells in the rodent placenta","volume":"54","author":"Hu","year":"2010","journal-title":"Int. J. Dev. Biol."},{"issue":"3","key":"10.1016\/j.bbadis.2025.167822_bb0200","doi-asserted-by":"crossref","first-page":"H1421","DOI":"10.1152\/ajpheart.00031.2006","article-title":"Developmental changes in hemodynamics of uterine artery, utero- and umbilicoplacental, and vitelline circulations in mouse throughout gestation","volume":"291","author":"Mu","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.bbadis.2025.167822_bb0205","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1309\/AJCPRHM8CZH5EMFD","article-title":"The vascular marker CD31 also highlights histiocytes and histiocyte-like cells within cutaneous tumors","volume":"143","author":"Vanchinathan","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"issue":"43","key":"10.1016\/j.bbadis.2025.167822_bb0210","doi-asserted-by":"crossref","first-page":"E5815","DOI":"10.1073\/pnas.1509627112","article-title":"CD31 signals confer immune privilege to the vascular endothelium","volume":"112","author":"Cheung","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbadis.2025.167822_bb0215","series-title":"The Guide to Investigation of Mouse Pregnancy","first-page":"180","article-title":"Pathology analysis of the placenta","author":"Bolon","year":"2014"},{"issue":"5","key":"10.1016\/j.bbadis.2025.167822_bb0220","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.fertnstert.2003.12.016","article-title":"\u201cFirst uterine pass effect\u201d is observed when estradiol is placed in the upper but not lower third of the vagina","volume":"81","author":"Cicinelli","year":"2004","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.bbadis.2025.167822_bb0225","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1749-6632.1997.tb48550.x","article-title":"The first uterine pass effect","volume":"828","author":"De Ziegler","year":"1997","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"7","key":"10.1016\/j.bbadis.2025.167822_bb0230","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/ckj\/sfac060","article-title":"Kidney-placenta crosstalk in health and disease","volume":"15","author":"Cabarcas-Barbosa","year":"2022","journal-title":"Clin. Kidney J."},{"issue":"3","key":"10.1016\/j.bbadis.2025.167822_bb0235","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/j.seminhematol.2021.06.003","article-title":"Advances in understanding the crosstalk between mother and fetus on iron utilization","volume":"58","author":"Lakhal-Littleton","year":"2021","journal-title":"Semin. Hematol."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167822_bb0240","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1038\/s41467-024-48492-x","article-title":"Pulmonary maternal immune activation does not cross the placenta but leads to fetal metabolic adaptation","volume":"15","author":"Hansen","year":"2024","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bbadis.2025.167822_bb0245","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00280-013-2284-9","article-title":"Population pharmacokinetics of dimethylacetamide in children during standard and once-daily IV busulfan administration","volume":"72","author":"Trame","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"13","key":"10.1016\/j.bbadis.2025.167822_bb0250","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1200\/JCO.2006.08.8807","article-title":"Cytotoxicity of dimethylacetamide and pharmacokinetics in children receiving intravenous busulfan","volume":"25","author":"Hempel","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.bbadis.2025.167822_bb0255","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0378-4274(94)90061-2","article-title":"Dimethylacetamide pharmacokinetics following inhalation exposures to rats and mice","volume":"73","author":"Hundley","year":"1994","journal-title":"Toxicol. Lett."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392500167X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392500167X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T08:34:49Z","timestamp":1749544489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092544392500167X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S092544392500167X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167822","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.01.16.633348","asserted-by":"object"}]},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving the safety of N,N-dimethylacetamide (DMA) as a potential treatment for preterm birth in a pregnant mouse model using a vaginal nanoformulation","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167822","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"167822"}}